Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Leonard John M.
Relationship:  
City:   North Chicago
State:   IL
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   1,085,175    

Indirect Shares

   64,888      
Direct Value   $43,029,972    

Indirect Value

   $2,424,429      
Total Shares   1,150,063      
Total Value   $45,454,401      


Abbvie Inc. $18,182,154 Chimerix Inc $3,734 IQVIA Holdings Inc $3,021,647 Intellia Therapeutics, Inc. $21,822,437 Abbvie Inc. $18,182,154 Chimerix Inc $3,734 IQVIA Holdings Inc $3,021,647 Intellia Therapeutics, Inc. $21,822,437
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 80.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Abbvie Inc. ABBV SVP, Chief Scientific ... 2013-03-15 107,320 2013-03-15 6,473    Premium*  
            Chimerix Inc CMRX Director 2015-08-21 4,000 2016-09-15 0    Premium*  
            IQVIA Holdings Inc IQV Director 2024-05-07 13,783 2015-03-04 0    Premium*  
            Intellia Therapeutics, Inc. NTLA 2024-03-01 960,072 2024-03-01 58,415    Premium*  
* Premium Members only  

Records found :    75         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2020-11-25 4 AS $36.00 $1,800,000 D/D (50,000) 467,352 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2020-11-27 4 AS $38.00 $1,350,000 D/D (35,000) 467,352 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-02-01 4 AS $63.24 $7,032,905 D/D (109,889) 565,599 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-02-03 4 AS $72.00 $4,922,490 D/D (67,856) 614,803 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-02-05 4 AS $67.18 $1,552,185 D/D (22,942) 631,861 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-02-09 4 AS $75.00 $2,103,225 D/D (28,043) 660,536 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-04-01 4 AS $83.00 $3,195,661 D/D (38,209) 693,368 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-08-19 4 AS $150.46 $3,431,398 D/D (22,682) 719,305 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-08-23 4 AS $151.54 $4,125,416 D/D (27,139) 719,305 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-08-30 4 AS $152.81 $6,051,353 D/D (38,804) 719,305 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-08-31 4 AS $155.00 $5,864,115 D/D (37,833) 719,305 0 %
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2021-09-01 4 AS $170.00 $7,604,950 D/D (44,735) 719,305 0 %
CMRX Chimerix Inc Director   –       •      –    2014-11-05 4 B $29.00 $116,000 D/D 4,000 4,000 2.39 -
CMRX Chimerix Inc Director   –       •      –    2015-08-21 4 B $47.38 $47,380 I/I 1,000 1,000 2.1 -
ABBV Abbvie Inc. SVP, Chief Scientific Officer   •       –      –    2013-02-19 4 D $37.58 $299,964 D/D (7,982) 144,676 0 -
ABBV Abbvie Inc. SVP, Chief Scientific Officer   •       –      –    2013-02-19 4 D $37.58 $952,465 D/D (25,345) 148,981 0 -
ABBV Abbvie Inc. SVP, Chief Scientific Officer   •       –      –    2013-02-28 4 D $36.73 $345,519 D/D (9,407) 135,269 0 -
ABBV Abbvie Inc. SVP, Chief Scientific Officer   •       –      –    2013-02-19 4 OE $27.29 $809,267 D/D 29,650 174,326 0 -
ABBV Abbvie Inc. SVP, Chief Scientific Officer   •       –      –    2013-03-15 4 OE $28.86 $1,347,893 D/D 46,700 154,020 0 -
IQV IQVIA Holdings Inc Director   –       •      –    2019-12-20 4 OE $64.52 $1,308,254 D/D 20,200 28,452 0 -
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2020-06-03 4 OE $6.83 $34,150 D/D 5,000 472,352 0 -
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2020-07-01 4 OE $6.83 $34,150 D/D 5,000 472,352 0 -
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2020-08-06 4 OE $6.83 $34,150 D/D 5,000 472,352 0 -
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2020-09-01 4 OE $6.83 $34,150 D/D 5,000 472,352 0 -
NTLA Intellia Therapeutics, In... President and CEO   •       •      –    2020-10-07 4 OE $6.83 $34,150 D/D 5,000 472,352 0 -
  75  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us